Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ONO 3403

Known as: ONO-3403 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Protease-antiprotease imbalance and oxidative stress are considered to be major pathophysiological hallmarks of severe… Expand
Is this relevant?
2011
2011
Thymidylate synthase (TS) plays a major role in the response to 5‐fluorouracil (5‐FU) by binding directly to the 5‐FU metabolite… Expand
Is this relevant?
2004
2004
The effects of a synthetic serine protease inhibitor, FOY-305, and its derivatives, ONO-3403 and FO-349, on the proliferation of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2002
2002
FOY-305 is a synthetic serine protease inhibitor and ONO-3403 is a derivative with a higher protease-inhibitory activity. The… Expand
Is this relevant?
2001
2001
The new serine protease inhibitor, ONO-3403 is an analog of FOY-305 (Foypan). The IC50s values of ONO-3403 toward serine… Expand
Is this relevant?
1999
1999
The effects of oral administration of two synthetic trypsin inhibitors (camostate and ONO-3403) and soybean trypsin inhibitor… Expand
Is this relevant?
1998
1998
FOY-305 is a synthetic serine protease inhibitor and ONO-3403 and FO-349 are its derivatives. The effects of these compounds on… Expand
Is this relevant?
1998
1998
Tumor invasion into the extracellular matrix (ECM) and basement membrane (BM) is a crucial step of tumor metastasis. In order to… Expand
Is this relevant?
1997
1997
FOY-305 is a synthetic serine protease inhibitor and ONO-3403 and FO-349 are its derivatives. The effects of these compounds on… Expand
Is this relevant?
1996
1996
ONO-3403 and ONO-5046 are potent synthetic protease inhibitors of trypsin and elastase, respectively. These compounds suppressed… Expand
Is this relevant?